IMBA PHD PROGRAMME · Research Training in functional Genomics and molecular Medicine
6РП — Действия „Мария Кюри“
- Период
- 2006-06-01 → 2010-05-31
- Финансиране от ЕС
- 671 766 €
- Участници
- 1
- Схема
- EST
Линиите свързват координатора с партньорите. За проекти отпреди 2014 г. CORDIS не винаги дава точни координати. Тези точки са на ниво град или държава.
Накратко на български
Молекулярните механизми на заболеванията се изучават чрез примери като контрола на микроРНК при тетрахимената и биологията на стволовите клетки при плодовата мушка. Това помага за по-доброто разбиране на функционирането на гените и развитието на молекулярната медицина.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Final Activity Report Summary - IMBA PHD PROGRAMME (Research training in functional genomics and molecular medicine)
The goal of this project was to establish an international PhD programme at the Institute of Molecular Biotechnology in Vienna. The institute conducted a broad range of biomedical research activities whose common goal was to understand the molecular mechanisms of disease. Student education was been established in conjunction with the pre-existing PhD programme at the Vienna Biocenter. During the course of the project, four PhD students successfully conducted research towards obtaining a PhD. Their research activities covered a broad area ranging from the control of micro ribonucleic acids (RNAs) in tetrahymena to stem cell biology in the fruit fly drosophila. Research activities were complemented by an extensive training programme, which included a lecture series on diverse topics in highly active research areas. Students also had the opportunity to organise an annual scientific conference together with the Vienna Biocenter (VBC) PhD program and to invite seminar speakers within the institute's weekly international seminar programme. The progress of the PhD students was monitored by a committee of three scientists from local institutes who evaluated the research performed and also took on mentoring activities for the students. The programme was highly successful. Of the four students recruited, two successfully obtained their PhD while the other two were expected to graduate within the few months following the project completion.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Medicine will be revolutionized by the introduction of novel therapeutics that targets the underlying molecular and genetic mechanisms of disease. Targeting of defined genes using functional genomics has been proven to be particularly useful since loss of expression mutants reveal essential functions of molecules in normal physiology and the pathogenesis of multiple diseases. IMBA, a new Centre of Excellence founded by the Austrian Academy of Sciences, will create a new PhD programme, which will operate in collaboration with the University of Vienna/IMP international PhD programme.A primary goal of the proposed IMBA PhD project is to train early stage researchers in the applications of functional genomics to understand the pathogenesis of human diseases and t o generate genetic animal models for cancer and cardiovascular diseases. The multidisciplinary training programme at IMBA will expose early stage researchers to state-of-the-art technologies in functional genetics ranging from work in different genetic mod el organisms, the biochemical elucidation of novel disease pathways, to innovative in vivo imaging of biological processes.This training will position early stage PhD students to become productive and independent scientists in Europe. Our programme is designed to become a European Centre of Excellence in basic research and an international training centre for PhD students in post genomic research. Research training in excellent laboratory environments will be complemented by lecture courses covering modern biomedical methodology, scientific career opportunities and latest developments in biomedical research and development of presentation skills. Identification of new disease genes will also allow us to promote biotechnology industry in Europe via the set-up of small start-up companies.Students will therefore be exposed to a biotechnology oriented academic environment. The project will strongly contribute to a European critical mass of knowledge and expertise.
Оригинален текст от CORDIS (на английски).
Участници
- INSTITUTE FUER MOLEKULARE BIOTECHNOLOGIE GMBH · VIENNAКоординаторНиво градАвстрия
Връзки
Данни: CORDIS, © Европейски съюз